노보큐어(NVCR)는 NASDAQ에 상장된 Healthcare · Medical Devices 기업입니다. 현재가 $16.73 (+0.06%), 시가총액 $2.04B, 52주 최저~최고 $10.03 ~ $19.40.
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax. The company also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.
노보큐어의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.
노보큐어의 현재 주가는 $16.73 (+0.06%)입니다. BlackAll Trade에서 실시간 시세와 차트를 확인할 수 있습니다.
노보큐어의 시가총액은 약 $2.04B입니다.
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United